61 related articles for article (PubMed ID: 447326)
1. Complement's alternate pathway.
Ward AN
Hosp Pract; 1979 Jun; 14(6):24. PubMed ID: 447326
[No Abstract] [Full Text] [Related]
2. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall.
Winkelstein JA; Abramovitz AS; Tomasz A
J Immunol; 1980 May; 124(5):2502-6. PubMed ID: 7365262
[No Abstract] [Full Text] [Related]
3. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci.
Edwards MS; Kasper DL; Jennings HJ; Baker CJ; Nicholson-Weller A
J Immunol; 1982 Mar; 128(3):1278-83. PubMed ID: 7035562
[No Abstract] [Full Text] [Related]
4. An affinity for complement C3 as a possible reason for the potency of naturally occurring antibodies in mediating tissue homeostasis.
Lutz HU; Fasler S; Stammler P
Beitr Infusionsther; 1989; 24():193-9. PubMed ID: 2481539
[TBL] [Abstract][Full Text] [Related]
5. Steady state relations between control proteins regulating the formation of the alternative pathway C3 convertase.
Reeve J; Woo PM
Immunology; 1982 Aug; 46(4):859-66. PubMed ID: 6921154
[TBL] [Abstract][Full Text] [Related]
6. Activation of the alternative complement pathway by isolated human glomerular basement membrane.
Williams JD; Czop JK; Abrahamson DR; Davies M; Austen KF
J Immunol; 1984 Jul; 133(1):394-9. PubMed ID: 6373930
[TBL] [Abstract][Full Text] [Related]
7. [Specific measurement of alternate pathway activation of complement in human glomerulonephritides (GN): 125 cases (author's transl)].
Berthoux FC; Freyria AM
Nephrologie; 1980; 1(2):61-6. PubMed ID: 7301022
[TBL] [Abstract][Full Text] [Related]
8. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
Moore FD; Austen KF; Fearon DT
J Immunol; 1982 Mar; 128(3):1302-6. PubMed ID: 6915957
[TBL] [Abstract][Full Text] [Related]
9. Attachment of [35S]cysteine to the labile site of the third component of complement via the alternative pathway.
Rutherford CJ; Alper CA; Rosen FS; Babior BM
Clin Immunol Immunopathol; 1983 Jan; 26(1):76-82. PubMed ID: 6872338
[TBL] [Abstract][Full Text] [Related]
10. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
Mold C; Nemerow GR; Bradt BM; Cooper NR
J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
[TBL] [Abstract][Full Text] [Related]
11. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
Schenkein HA; Ruddy S
J Immunol; 1981 Jan; 126(1):11-5. PubMed ID: 6905857
[No Abstract] [Full Text] [Related]
12. Inhibition of complement by gold sodium thiomalate.
Hasselbacher P
J Rheumatol; 1981; 8(1):57-61. PubMed ID: 6783754
[TBL] [Abstract][Full Text] [Related]
13. Activation of the alternative pathway of complement by Malassezia ovalis (Pityrosporum ovale).
Belew PW; Rosenberg EW; Jennings BR
Mycopathologia; 1980 Mar; 70(3):187-91. PubMed ID: 6900183
[TBL] [Abstract][Full Text] [Related]
14. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
Kaneko I; Fearon DT; Austen KF
J Immunol; 1980 Mar; 124(3):1194-8. PubMed ID: 6898640
[No Abstract] [Full Text] [Related]
17. Effect of gangliosides on activation of the alternative pathway of human complement.
Michalek MT; Bremer EG; Mold C
J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
[TBL] [Abstract][Full Text] [Related]
18. Alternative pathway complement activation in rheumatoid arthritis.
El-Ghobarey A; Whaley K
J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
20. The third component of complement: covalent attachment of a radioactive sugar to the labile binding site of C3 via the alternative pathway.
Mann J; O'Brien R; Hostetter MK; Alper CA; Rosen FS; Babior BM
J Immunol; 1981 Jun; 126(6):2370-2. PubMed ID: 6785350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
